Search Results for "Insight Pharma Reports Epigenetics"

09:52 EDT 27th May 2015 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

CurrentPartnering

CurrentPartnering was established in 2007 to offer an objective and informal business tool for business development executives, providing an opportunity for the dissemination of the latest trends in...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...

OxyContin

OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...

Matching News

Zenith Epigenetics – bromodomain inhibitors

Zenith Epigenetics is a biotech company developing bromodomain (BET) inhibitors for the treatment of cancer and autoimmune disorders. Zenith Epigenetics aims to become a leading epigenetic company tra...

Five year funding commitment for new Alberta epigenetics network

Calgary, AB- The Government of Alberta, along with Alberta’s three largest research universities are providing $1.2million in support to the Alberta Epigenetics Network . Epigenetics directly af...

Super drugs

Nigel Theobald, N4 Pharma offers an insight into the company’s latest offerings to the pharma sector

EMBO Conference: Chromatin and Epigenetics

This EMBO Conference: Chromation and Epigenetics will be held at the EMBL Advanced Training Centre in Heidelberg Wednesday 6 May - Sunday 10 May 2015. Registration is possible until 25 March 2015.

Pharma adverse event FDA reports are inadequate

Reports of adverse drug events submitted to the FDA by pharma firms are often incomplete and lacking in detail, a new study has found. Researchers from the US Institute for Safe Medication Practices l...

Gilead buys EpiTherapeutics for $65 million

Gilead is clearly eyeing a future market involving epigenetics as the US firm buys Danish company EpiTherapeutics for $65 million. Epigenetics is the study of how environmental influences alter whethe...

Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets

(PRWEB) December 25, 2014 Epigenetics finds applications in a large number of fields of life science research, including oncology, drug discovery, developmental biology, and research for metabolic ...

Genetics: Mapping autoimmune disease epigenetics: what's on the horizon?

Can a patient's genotype provide insight into the mechanistic basis of autoimmune disease? A study integrating epigenetic data with finely mapped disease-associated variants sheds light on how noncodi...

Matching PubMed Articles

Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.

Hélène Montpetit has a Bachelor of Science in Biochemistry from the University du Québec at Montreal. For the past 15 years, she has worked in the bioanalysis field in CROs environment as well as i...

Epigenetics: Novel Therapeutics Targeting Epigenetics.

Barcelona Conference on Epigenetics and Cancer: 50 years of Histone Acetylation.

The Barcelona Conference on Epigenetics and Cancer (BCEC) was held in Barcelona, Spain, on October 1(st) and 2(nd), 2014. The meeting was co-organized by the Cancer Epigenetics and Biology Program (PE...

Epigenetics: general characteristics and implications for oral health.

Genetic information such as DNA sequences has been limited to fully explain mechanisms of gene regulation and disease process. Epigenetic mechanisms, which include DNA methylation, histone modificatio...

The premium of a big pharma license deal.

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement